Intuitive Surgical, Inc. (LON:0R29)

Market Cap	127.43B
Revenue (ttm)	6.67B
Net Income (ttm)	1.90B
Shares Out	n/a
EPS (ttm)	5.23
PE Ratio	66.95
Forward PE	55.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,992
Average Volume	1,853
Open	483.20
Previous Close	478.70
Day's Range	475.16 - 483.20
52-Week Range	406.50 - 616.00
Beta	1.60
RSI	40.86
Earnings Date	Oct 14, 2025

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 15,638
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R29

Financial Performance

In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.

Financial numbers in USD